Curcumin is an IL-6 inhibitor that has been previously used in a human gastric cancer xenograft model and mouse colon cancer model, demonstrating the inhibition of tumor growth, MDSCs in both blood and tumor tissue, and IL-6 levels. This evidence concerns the gene IL6 and neoplasm.